Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
MannKind Earnings Preview
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.
Analysts estimate that MannKind will report an earnings per share (EPS) of $-0.10.
MannKind Announced Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30
MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it has presented a poster [Abstract #445] at the 15th International Conference on Advanced Technologies & Treatments for Dia
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
68 Biggest Movers From Yesterday
Gainers
ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
4 Penny Stocks Insiders Are Buying: MannKind, Crexendo And More
Russian unemployment rate rose to a five-month high of 4.4% in January from 4.3% in the prior month. Investors, meanwhile, focused on some notable insider trades
41 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday.
HC Wainwright & Co. Maintains Buy on MannKind, Lowers Price Target to $6
HC Wainwright & Co. analyst Oren Livnat maintains MannKind (NASDAQ:MNKD) with a Buy and lowers the price target from $6.5 to $6.
93 Biggest Movers From Friday
Gainers
Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
